Depressive Disorder, Major

"Depressive Disorder, Major" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.

Descriptor ID	D003865
MeSH Number(s)	F03.600.300.375
Concept/Terms	Depressive Disorder, Major Depressive Disorder, Major Depressive Disorders, Major Disorder, Major Depressive Disorders, Major Depressive Major Depressive Disorders Major Depressive Disorder Psychosis, Involutional Psychosis, Involutional Involutional Psychoses Involutional Psychosis Psychoses, Involutional Paraphrenia, Involutional Paraphrenia, Involutional Involutional Paraphrenia Involutional Paraphrenias Paraphrenias, Involutional Depression, Involutional Depression, Involutional Involutional Depression Melancholia, Involutional Involutional Melancholia

Below are MeSH descriptors whose meaning is more general than "Depressive Disorder, Major".

Psychiatry and Psychology [F]
Mental Disorders [F03]
Mood Disorders [F03.600]
Depressive Disorder [F03.600.300]
Depressive Disorder, Major [F03.600.300.375]

Below are MeSH descriptors whose meaning is related to "Depressive Disorder, Major".

Below are MeSH descriptors whose meaning is more specific than "Depressive Disorder, Major".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Depressive Disorder, Major" by people in this website by year, and whether "Depressive Disorder, Major" was a major or minor topic of these publications.

Bar chart showing 288 publications over 23 distinct years, with a maximum of 26 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	2	0	2
2001	1	0	1
2002	3	1	4
2003	7	2	9
2004	8	1	9
2005	11	2	13
2006	8	2	10
2007	3	3	6
2008	10	3	13
2009	10	2	12
2010	7	4	11
2011	5	0	5
2012	8	1	9
2013	7	1	8
2014	14	1	15
2015	13	1	14
2016	18	2	20
2017	22	4	26
2018	18	5	23
2019	20	4	24
2020	22	1	23
2021	21	1	22
2022	9	0	9

Below are the most recent publications written about "Depressive Disorder, Major" by people in Profiles.

Swann AC, Graham DP, Wilkinson AV, Kosten TR. Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking. J Clin Psychiatry. 2022 06 06; 83(3).

View in: PubMed
Dorfschmidt L, Bethlehem RA, Seidlitz J, Váša F, White SR, Romero-García R, Kitzbichler MG, Aruldass AR, Morgan SE, Goodyer IM, Fonagy P, Jones PB, Dolan RJ, Harrison NA, Vértes PE, Bullmore ET. Sexually divergent development of depression-related brain networks during healthy human adolescence. Sci Adv. 2022 05 27; 8(21):eabm7825.

View in: PubMed
Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440.

View in: PubMed
Fang F, Godlewska B, Cho RY, Savitz SI, Selvaraj S, Zhang Y. Effects of escitalopram therapy on functional brain controllability in major depressive disorder. J Affect Disord. 2022 08 01; 310:68-74.

View in: PubMed
Kritzer MD, Mischel NA, Young JR, Lai CS, Masand PS, Szabo ST, Mathew SJ. Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. Ann Clin Psychiatry. 2022 02; 34(1):33-43.

View in: PubMed
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. J Affect Disord. 2022 04 15; 303:91-97.

View in: PubMed
Hunt C, Exline JJ, Fletcher TL, Teng EJ. Intolerance of uncertainty prospectively predicts the transdiagnostic severity of emotional psychopathology: Evidence from a Veteran sample. J Anxiety Disord. 2022 03; 86:102530.

View in: PubMed
Paul ER, Schwieler L, Erhardt S, Boda S, Trepci A, Kämpe R, Asratian A, Holm L, Yngve A, Dantzer R, Heilig M, Hamilton JP, Samuelsson M. Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav Immun. 2022 03; 101:136-145.

View in: PubMed
Murphy N, Lijffijt M, Ramakrishnan N, Vo-Le B, Vo-Le B, Iqbal S, Iqbal T, O'Brien B, Smith MA, Swann AC, Mathew SJ. Does mismatch negativity have utility for NMDA receptor drug development in depression? Braz J Psychiatry. 2022 Jan-Feb; 44(1):61-73.

View in: PubMed
Schneider BS, Arciniegas DB, Harenski C, Clarke GJB, Kiehl KA, Koenigs M. The prevalence, characteristics, and psychiatric correlates of traumatic brain injury in incarcerated individuals: an examination in two independent samples. Brain Inj. 2021 12 06; 35(14):1690-1701.

View in: PubMed

People

Explore

Similar Concepts

Top Journals